← Deal Flow

Neomorph

Deep
1Rounds
1Articles
General InformationNeomorph appears to be an early-stage deep-tech company, though specific details about its location, employee count, and founding date are not publicly confirmed in accessible sources.
Funding & FinancialsNo confirmed funding information is available for Neomorph from public sources, suggesting it may be in pre-seed or stealth stage.
Leadership & TeamLeadership and team composition for Neomorph could not be verified from available public information.
Recent ActivityRecent activity or product developments for Neomorph are not documented in accessible public sources, consistent with an early-stage or stealth-mode operation.

Highlights

Total Raised
1 rounds
Latest Round
$100
May 2, 2026
Stage
deep-tech
Employees
Headquarters
News Coverage
1 articles
Last: 2mo ago
Talent Signals
1 moves
SEC Filings

Backers

Alexandria Venture Investments
Binney Street Capital
Deerfield Management
Longwood Fund
Regeneron Ventures

Funding History

$100
2026
Series B
SEC Form D   Editorial
May 2, 2026
$100 millionSeries B · Editorial

Investors: Deerfield Management, Regeneron Ventures, Longwood Fund, Alexandria Venture Investments, Binney Street Capital

Biotech company developing molecular glue degrader therapies raised $100 million Series B to advance its pipeline for cancer treatment.

News Coverage 1

Talent 1

Cam Wheeler
appointmentChair of Neomorph's boardApr 14, 2026
Source →

Similar Companies 6